Amphastar P

Amphastar P

Yahoo Finance • last month

1 Healthcare Stock to Consider Right Now and 2 We Brush Off

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six... Full story

Yahoo Finance • last month

Amphastar Pharmaceuticals, Inc. (AMPH) Price Target Cut to $21 At Piper Sandler Amid Pipeline Uncertainty

We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is one of the most undervalued pharma stocks. TheFly reported on May 11 that Piper Sandler reduced its price... Full story

Yahoo Finance • 2 months ago

Q4 Earnings Highlights: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Amneal (NASDAQ:AMRX) and the best and worst performers in the generic pharmaceutic... Full story

Yahoo Finance • 2 months ago

3 Stocks Under $50 with Open Questions

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models... Full story

Yahoo Finance • 2 months ago

How The Amphastar Pharmaceuticals (AMPH) Narrative Is Shifting As Targets Fall And New Drugs Launch

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. The analyst modeled fair value for Amphastar Pharmaceuticals was trimmed from US$28.00 to about US... Full story

Yahoo Finance • 2 months ago

1 Cash-Producing Stock for Long-Term Investors and 2 We Turn Down

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. Luckily for you, we built StockStory t... Full story

Yahoo Finance • 3 months ago

Amphastar Pharmaceuticals (AMPH): Buy, Sell, or Hold Post Q4 Earnings?

Over the last six months, Amphastar Pharmaceuticals’s shares have sunk to $22.73, producing a disappointing 6.3% loss - a stark contrast to the S&P 500’s 5.8% gain. This was partly driven by its softer quarterly results and might have inve... Full story

Yahoo Finance • 3 months ago

1 Healthcare Stock to Target This Week and 2 We Avoid

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have seen decent returns lately as healthcare stocks were up 4.3% over the past six months, almost identical t... Full story

Yahoo Finance • 4 months ago

NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries. The retreat in oil prices provided temporary relief to a market that was volatil... Full story

Yahoo Finance • 4 months ago

Wells Fargo Sees Amphastar Pharmaceuticals, Inc.’s (AMPH) AMP-007 as Key to Mid- to High-Single-Digit Growth

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts.Wells Fargo Sees Amphastar Pharmaceuticals, Inc.'s (AMPH) AMP-007 as Key to Mid- to High-Single-Digit Growth T... Full story

Yahoo Finance • 7 months ago

Amphastar Director Sells 16,679 Shares for $441,800

Key Points Floyd Petersen exercised and sold 16,679 shares of Amphastar in November, pocketing more than $441,000. He still retains about $2 million worth of shares. These 10 stocks could mint the next wave of millionaires › Floyd Peters... Full story

Yahoo Finance • 7 months ago

Weekly Buzz: CYTK Scores First FDA Approval, INSM Ends Rhinosinusitis Study, XOMA Acquires GBIO

(RTTNews) - The biotech industry witnessed several key events this week, including major FDA approvals, acquisitions, pivotal clinical trial results and setbacks. • A series of FDA approvals were announced during the week, with GSK, Haloz... Full story

Yahoo Finance • 7 months ago

Will FDA Approval of an In‑House Teriparatide Pen Reshape Amphastar Pharmaceuticals' (AMPH) Narrative?

In December 2025, Amphastar Pharmaceuticals announced that the FDA approved its abbreviated new drug application for a teriparatide injection prefilled pen, deemed bioequivalent and therapeutically equivalent to Eli Lilly’s FORTEO, with pl... Full story

Yahoo Finance • 7 months ago

Amphastar Announces FDA Approval for Teriparatide Injection

RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbreviated New Drug Application ("ANDA") fo... Full story

Yahoo Finance • 7 months ago

My Bunny Portfolio Has Averaged a 13.7% Return

This article first appeared on GuruFocus. By John DorfmanDecember 8, 2025 (Maple Hill Syndicate) Today's column marks the 25th time I've written about a special collection of stocks I call the Bunny Portfolio, named after the Energizer B... Full story

Yahoo Finance • 8 months ago

The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a fur... Full story

Yahoo Finance • 8 months ago

Here are the major earnings after the close Thursday

Major earnings expected after the bell on Thursday include: * Block (XYZ [https://seekingalpha.com/symbol/XYZ]) * The Trade Desk (TTD [https://seekingalpha.com/symbol/TTD]) * Airbnb (ABNB [https://seekingalpha.com/symbol/ABNB]) *... Full story

Yahoo Finance • 9 months ago

Align Technology, Envista, Centene, Amphastar Pharmaceuticals, and Oscar Health Shares Plummet, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling... Full story

Yahoo Finance • 10 months ago

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Presents a Compelling Value Investment Case

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH [https://www.chartmill.com/stock/quote/AMPH/profile]) has been identified as a potential candidate for value investors through a screening process that emphasizes strong fundamental valuation whil... Full story

Yahoo Finance • 11 months ago

Bullish Two Hundred Day Moving Average Cross - AMPH

In trading on Friday, shares of Amphastar Pharmaceuticals Inc (Symbol: AMPH) crossed above their 200 day moving average of $47.00, changing hands as high as $48.04 per share. Amphastar Pharmaceuticals Inc shares are currently trading up a... Full story